•
Dec 31, 2010

Jazz Pharmaceuticals Q4 2010 Earnings Report

Total Revenue
$53.4M
Previous year: $128M
-58.5%
EPS
$0.88
Previous year: -$0.23
-482.6%
Gross Profit
$48.6M
Previous year: $35.5M
+36.9%
Cash and Equivalents
$44.8M
Previous year: $15.6M
+187.2%
Total Assets
$136M

Jazz Pharmaceuticals

Jazz Pharmaceuticals